Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2.

Shihui Sun, Hongjing Gu, Lei Cao, Qi Chen, Qing Ye, Guan Yang, Rui-Ting Li, Hang Fan, Yong-Qiang Deng, Xiaopeng Song, Yini Qi, Min Li, Jun Lan, Rui Feng, Yan Guo, Na Zhu, Si Qin, Lei Wang, Yi-Fei Zhang, Chao Zhou, Lingna Zhao, Yuehong Chen, Meng Shen, Yujun Cui, Xiao Yang, Xinquan Wang, Wenjie Tan, Hui Wang, Xiangxi Wang, Cheng-Feng Qin
Author Information
  1. Shihui Sun: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China. ORCID
  2. Hongjing Gu: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  3. Lei Cao: CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
  4. Qi Chen: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  5. Qing Ye: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  6. Guan Yang: State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
  7. Rui-Ting Li: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  8. Hang Fan: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China. ORCID
  9. Yong-Qiang Deng: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China. ORCID
  10. Xiaopeng Song: State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
  11. Yini Qi: State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
  12. Min Li: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  13. Jun Lan: CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
  14. Rui Feng: CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
  15. Yan Guo: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  16. Na Zhu: National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China. ORCID
  17. Si Qin: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  18. Lei Wang: CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.
  19. Yi-Fei Zhang: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  20. Chao Zhou: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China. ORCID
  21. Lingna Zhao: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  22. Yuehong Chen: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  23. Meng Shen: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  24. Yujun Cui: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China.
  25. Xiao Yang: State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China. ORCID
  26. Xinquan Wang: The Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, Collaborative Innovation Center for Biotherapy, School of Life Sciences, Tsinghua University, Beijing, 100084, China. ORCID
  27. Wenjie Tan: National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, 102206, China. ORCID
  28. Hui Wang: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China. geno0109@vip.sina.com.
  29. Xiangxi Wang: CAS Key Laboratory of Infection and Immunity, National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China. xiangxi@ibp.ac.cn. ORCID
  30. Cheng-Feng Qin: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China. qincf@bmi.ac.cn. ORCID

Abstract

There is an urgent need for animal models to study SARS-CoV-2 pathogenicity. Here, we generate and characterize a novel mouse-adapted SARS-CoV-2 strain, MASCp36, that causes severe respiratory symptoms, and mortality. Our model exhibits age- and gender-related mortality akin to severe COVID-19. Deep sequencing identified three amino acid substitutions, N501Y, Q493H, and K417N, at the receptor binding domain (RBD) of MASCp36, during in vivo passaging. All three RBD mutations significantly enhance binding affinity to its endogenous receptor, ACE2. Cryo-electron microscopy analysis of human ACE2 (hACE2), or mouse ACE2 (mACE2), in complex with the RBD of MASCp36, at 3.1 to 3.7 Å resolution, reveals the molecular basis for the receptor-binding switch. N501Y and Q493H enhance the binding affinity to hACE2, whereas triple mutations at N501Y/Q493H/K417N decrease affinity and reduce infectivity of MASCp36. Our study provides a platform for studying SARS-CoV-2 pathogenesis, and unveils the molecular mechanism for its rapid adaptation and evolution.

References

  1. J Comput Chem. 2004 Oct;25(13):1605-12 [PMID: 15264254]
  2. Int Immunopharmacol. 2021 Jun;95:107493 [PMID: 33721758]
  3. Nature. 2020 May;581(7809):465-469 [PMID: 32235945]
  4. Science. 2020 Sep 18;369(6510):1505-1509 [PMID: 32703908]
  5. Nat Rev Immunol. 2020 Jul;20(7):442-447 [PMID: 32528136]
  6. J Exp Med. 2020 Dec 7;217(12): [PMID: 32750141]
  7. Lancet Neurol. 2020 Sep;19(9):767-783 [PMID: 32622375]
  8. J Infect. 2020 Jun;80(6):e14-e18 [PMID: 32171866]
  9. Lancet. 2020 Aug 1;396(10247):320-332 [PMID: 32682491]
  10. Clin Infect Dis. 2020 Jul 28;71(15):863-865 [PMID: 32232322]
  11. Endocrinology. 2012 Jun;153(6):2544-50 [PMID: 22434079]
  12. Nature. 2021 Apr;592(7852):116-121 [PMID: 33106671]
  13. Immun Ageing. 2020 May 21;17:13 [PMID: 32457811]
  14. N Engl J Med. 2014 Apr 3;370(14):1335-42 [PMID: 24693893]
  15. Lancet Respir Med. 2020 Apr;8(4):420-422 [PMID: 32085846]
  16. Cell. 2020 Nov 12;183(4):1070-1085.e12 [PMID: 33031744]
  17. Am J Respir Cell Mol Biol. 2011 May;44(5):725-38 [PMID: 21531958]
  18. Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21 [PMID: 20057044]
  19. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):347-352 [PMID: 32214086]
  20. Rev Med Virol. 2020 Sep;30(5):e2130 [PMID: 32656939]
  21. J Immunol. 2017 May 15;198(10):4046-4053 [PMID: 28373583]
  22. Int J Legal Med. 2020 Jul;134(4):1275-1284 [PMID: 32500199]
  23. Nat Commun. 2020 Oct 28;11(1):5453 [PMID: 33116139]
  24. Nat Rev Nephrol. 2021 Jan;17(1):46-64 [PMID: 33077917]
  25. Cell. 2020 Oct 1;183(1):13-15 [PMID: 32976799]
  26. Science. 2021 Apr 9;372(6538): [PMID: 33658326]
  27. Nat Med. 2019 Dec;25(12):1822-1832 [PMID: 31806905]
  28. Science. 2020 Sep 25;369(6511):1603-1607 [PMID: 32732280]
  29. J Med Virol. 2021 Apr;93(4):2177-2195 [PMID: 33095454]
  30. Ann Am Thorac Soc. 2018 Nov;15(Suppl 3):S143-S148 [PMID: 30431340]
  31. Nat Rev Immunol. 2016 Oct;16(10):626-38 [PMID: 27546235]
  32. J Clin Pathol. 2020 May;73(5):239-242 [PMID: 32198191]
  33. Intensive Care Med. 2020 Jun;46(6):1114-1116 [PMID: 32236644]
  34. Respir Res. 2020 Oct 27;21(1):282 [PMID: 33109186]
  35. Cell Rep. 2020 Oct 6;33(1):108234 [PMID: 32979938]
  36. Cold Spring Harb Perspect Biol. 2017 Apr 3;9(4): [PMID: 27864314]
  37. J Struct Biol. 2005 Oct;152(1):36-51 [PMID: 16182563]
  38. Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67 [PMID: 22505256]
  39. Nature. 2020 Jul;583(7818):830-833 [PMID: 32380511]
  40. J Med Virol. 2020 Apr;92(4):418-423 [PMID: 31967327]
  41. Nat Rev Microbiol. 2021 Mar;19(3):141-154 [PMID: 33024307]
  42. Nat Commun. 2021 May 4;12(1):2506 [PMID: 33947851]
  43. Nat Commun. 2020 Aug 6;11(1):3910 [PMID: 32764693]
  44. Nature. 2020 Oct;586(7830):560-566 [PMID: 32854108]
  45. Cell. 2020 Aug 6;182(3):734-743.e5 [PMID: 32643603]
  46. Immunology. 2020 Jul;160(3):261-268 [PMID: 32460357]
  47. Protein Cell. 2020 Oct;11(10):776-782 [PMID: 32749592]
  48. Pathog Dis. 2020 Apr 1;78(3): [PMID: 32533838]
  49. Lancet. 2003 May 24;361(9371):1773-8 [PMID: 12781536]
  50. Acta Crystallogr D Biol Crystallogr. 2015 Jan 1;71(Pt 1):136-53 [PMID: 25615868]
  51. Mod Pathol. 2020 Jun;33(6):1007-1014 [PMID: 32291399]
  52. Nature. 2020 May;581(7807):215-220 [PMID: 32225176]
  53. PLoS Pathog. 2021 Mar 24;17(3):e1009392 [PMID: 33760889]
  54. Lancet Infect Dis. 2020 May;20(5):515-516 [PMID: 32213336]
  55. Nature. 2020 Mar;579(7798):265-269 [PMID: 32015508]
  56. J Struct Biol. 2012 Dec;180(3):519-30 [PMID: 23000701]

Grants

  1. 81925025/National Science Foundation of China | Young Scientists Fund

MeSH Term

Amino Acid Substitution
Angiotensin-Converting Enzyme 2
Animals
Binding Sites
COVID-19
Disease Models, Animal
Female
Humans
Male
Mice
Protein Binding
Protein Domains
SARS-CoV-2
Severity of Illness Index
Spike Glycoprotein, Coronavirus

Chemicals

Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
Ace2 protein, mouse
Angiotensin-Converting Enzyme 2